edgepedia

Life and health

72,234 articles

Ion-translocating oxidoreductase complex, subunit RnfC/RsxC

RnfC/RsxC is the peripheral NADH-binding subunit of the bacterial Rnf ion-translocating ferredoxin:NAD+ oxidoreductase, carrying one FMN and two [4Fe-4S] clusters; its E. coli homolog RsxC reduces the SoxR stress sensor.

Ionic gelation

Ionic gelation is a mild, solvent-free encapsulation method that cross-links charged polymers with counter-ions in water to form hydrogel beads, microparticles, and nanoparticles for drugs and probiotics.

Ionis Pharmaceuticals

Ionis Pharmaceuticals (IONS), formerly Isis Pharmaceuticals, is a Carlsbad, California biotech pioneering antisense oligonucleotide (ASO) medicines. It markets SPINRAZA, QALSODY, WAINUA, TEGSEDI, WAYLIVRA, and TRYNGOLZA, and launched independently in 2025.

Ionizable lipid

An ionizable lipid is a synthetic lipid that is neutral at physiological pH but positively charged in acidic endosomes, the key component of lipid nanoparticles for RNA delivery.

Ionizable lipid pKa optimization

Ionizable lipid pKa optimization tunes the protonation of ionizable lipids in lipid nanoparticles so they deliver RNA cargo efficiently, as in Onpattro and COVID-19 mRNA vaccines.

Ionocyte

Ionocyte: specialized ion-transporting epithelial cell (mitochondria-rich), first seen in fish gills; pulmonary ionocyte (FOXI1+, CFTR-high) discovered 2018 in airways, relevant to cystic fibrosis.

Ionotropic glutamate receptor

Ionotropic glutamate receptors (iGluRs) are tetrameric, cation-permeable ligand-gated ion channels mediating fast excitatory neurotransmission. Four classes: AMPA, kainate, NMDA, and GluD, encoded by 18 genes.

Iontophoresis

Iontophoresis is a drug delivery method that uses a small electric current to push charged drugs through the skin, and stimulates sweating for the cystic fibrosis sweat test.

Iopamidol

Iopamidol is a nonionic, low-osmolality iodinated contrast medium, sold as Isovue, Niopam, and Iopamiron, developed by Bracco and launched in 1981 for CT and angiography.

Iopanoic acid

Iopanoic acid (Telepaque), introduced 1951, is a triiodinated oral cholecystographic contrast medium for gallbladder X-ray imaging that also inhibits T4-to-T3 deiodinase and is used off-label for severe hyperthyroidism; tablets are discontinued.

Iophendylate

Iophendylate (Pantopaque, Myodil, iofendylate) is an oil-based iodinated X-ray contrast agent introduced in 1944 for myelography, ventriculography, and cisternography; poorly absorbed and linked to arachnoiditis, it was replaced by metrizamide in the 1970s.

Iopromide

Iopromide, marketed as Ultravist by Bayer, is a nonionic, low-osmolar, tri-iodinated X-ray contrast agent developed by Schering, launched in Europe in 1985, and sold in over 70 countries.

Iosif Gitel'son

Iosif Isaevich Gitel'son (1928–2022) was a Soviet and Russian biophysicist who founded the Krasnoyarsk school of biophysics, led the BIOS-3 closed life-support system, and won the Lomonosov Gold Medal.

Iothalamic acid

Iothalamic acid is a tri-iodinated benzoic acid derivative that serves as a high-osmolality X-ray contrast agent marketed as Conray, and its radioiodinated sodium salt measures glomerular filtration rate.

Iotrolan

Iotrolan (Isovist, Osmovist) is a non-ionic dimeric, iso-osmolar iodinated X-ray contrast medium (ATC V08AB06, MW 1626.24) used intrathecally for myelography and for arthrography; FDA-approved 1989, later discontinued in the US and Canada.

Ioversol

Ioversol, marketed as Optiray, is a nonionic, low-osmolar iodinated X-ray contrast agent approved in 1988 for angiography, CT of the head and body, venography, and urography.

Iowa Department of Public Health

Iowa Department of Public Health (IDPH), successor to the 1880 State Board of Health, was Iowa's state public health agency until merging with DHS on July 1, 2022 to form Iowa HHS under HF 2578.

Ioxilan

Ioxilan (Oxilan) is a nonionic, low-osmolar, triiodinated X-ray contrast agent approved by the FDA in 1995 (NDA 020316) for urography, CT, and arteriography; later discontinued.

Ioxitalamic acid

Ioxitalamic acid (Telebrix) is a first-generation ionic monomer iodinated X-ray contrast medium, a triiodobenzoic acid derivative with high osmolality, used for angiography, urography, hysterosalpingography, and CT enhancement.

Ioxynil

Ioxynil (4-hydroxy-3,5-diiodobenzonitrile, CAS 1689-83-4) is a hydroxybenzonitrile, photosystem II-inhibiting and uncoupling herbicide for broad-leaved weeds; EU approval expired 2015, banned under PIC from 2025.

IPA-CPP trial

IPA-CPP (NCT02867774) was a University of Michigan pilot trial testing an 8-week supervised moderate-intensity exercise program for pain, function, and quality of life in women with chronic pelvic pain.

iPACK block

The iPACK block, short for infiltration between the popliteal artery and capsule of the knee, is an ultrasound-guided technique relieving posterior knee pain after knee replacement while sparing motor function.

Iparomlimab and tuvonralimab (QL1706)

Iparomlimab and tuvonralimab (QL1706, 齐倍安) is Qilu Pharmaceutical's PD-1/CTLA-4 dual combination antibody, MabPair-produced in a fixed 2:1 ratio; NMPA conditionally approved it in September 2024 for recurrent or metastatic cervical cancer after platinum-chemotherapy failure.

Ipatasertib

Ipatasertib (GDC-0068, RG7440) is Genentech's oral ATP-competitive pan-AKT1/2/3 inhibitor tested in phase III breast and prostate cancer trials; phase III results were negative and it is not approved.

Ipconazole

Ipconazole is a triazole fungicide developed by Kureha in Japan and sold since 1994, used mainly as a seed treatment against soil-borne and seed-borne fungal diseases.

IPEC-J2

IPEC-J2 (Intestinal Porcine Epithelial Cell line-J2), a non-transformed porcine jejunal enterocyte line isolated in 1989 by Helen Berschneider; used for intestinal barrier, host-pathogen, probiotic, and nutrition studies, with high TEER in FBS culture.

IPF/ILD-PRO study

IPF/ILD-PRO (NCT01915511) is a prospective observational US registry run by Duke Clinical Research Institute with Boehringer Ingelheim, following over 2,000 people with IPF and progressive fibrotic ILD.

Ipflufenoquin

Ipflufenoquin (NF-180, Kinoprol, Migiwa, Rhapsody, Axios) is a quinoline DHODH-inhibiting fungicide from Nippon Soda, CAS 1314008-27-9, FRAC group 52, first US-registered 2022 for pome fruit and almond diseases.

iPHENAMIC study

iPHENAMIC (NCT02501070) is a retrospective cohort study of 6783 STEMI patients in northern Galicia, Spain, showing that the PROGALIAM regional infarct-care network lowered 5-year adjusted mortality and equalized survival across A Coruña, Lugo, and Ferrol.

iPhot study

iPhot study (NCT01546181), an INSERM observational follow-up study of adaptive optics retinal imaging in Paris (2010-2017), using the rtx1 camera to quantify photoreceptor density and retinal microstructures in health and disease.